Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Plasma CD105, TGFβ-1, TGFβ-3 and the Ligand/Receptor Complexes in Children with Acute Lymphoblastic Leukaemia

ABDULFATTAH AL-MOWALLAD, TREVOR CARR, ABDULLAH AL-QOUZI, CHENGGANG LI, RICHARD BYERS and SHANT KUMAR
Anticancer Research January 2006, 26 (1B) 543-547;
ABDULFATTAH AL-MOWALLAD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TREVOR CARR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ABDULLAH AL-QOUZI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHENGGANG LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RICHARD BYERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHANT KUMAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shant.kumar{at}manchester.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 26 no. 1B 543-547
PMID 
16739317

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 21, 2005
  • Accepted November 29, 2005
  • Published online January 1, 2006.

Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ABDULFATTAH AL-MOWALLAD1,
  2. TREVOR CARR2,
  3. ABDULLAH AL-QOUZI1,
  4. CHENGGANG LI1,
  5. RICHARD BYERS1,3 and
  6. SHANT KUMAR1,4
  1. 1Division of Laboratory and Regenerative Medicine. The University of Manchester, Oxford Road, Manchester, M13 9PT
  2. 2Department of Clinical Haematology, Royal Manchester Children Hospital, Hospital Road, Manchester, M27 1HA
  3. 3Department of Pathology, Manchester Royal Infirmary Hospital, Oxford Road, Manchester, M13 9WL
  4. 4Christie Hospital, Wilmslow Road, Manchester, M20 4BX, U.K.
  1. Correspondence to: Shant Kumar, Department of Pathology, Medical School, Manchester University, Manchester M13 9PT, U.K. Tel: 00 44 161275-5298, Fax: 00 44 161275-5289, e-mail: shant.kumar{at}manchester.ac.uk

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 1B
January-February 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Plasma CD105, TGFβ-1, TGFβ-3 and the Ligand/Receptor Complexes in Children with Acute Lymphoblastic Leukaemia
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Plasma CD105, TGFβ-1, TGFβ-3 and the Ligand/Receptor Complexes in Children with Acute Lymphoblastic Leukaemia
ABDULFATTAH AL-MOWALLAD, TREVOR CARR, ABDULLAH AL-QOUZI, CHENGGANG LI, RICHARD BYERS, SHANT KUMAR
Anticancer Research Jan 2006, 26 (1B) 543-547;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Plasma CD105, TGFβ-1, TGFβ-3 and the Ligand/Receptor Complexes in Children with Acute Lymphoblastic Leukaemia
ABDULFATTAH AL-MOWALLAD, TREVOR CARR, ABDULLAH AL-QOUZI, CHENGGANG LI, RICHARD BYERS, SHANT KUMAR
Anticancer Research Jan 2006, 26 (1B) 543-547;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models
  • Google Scholar

More in this TOC Section

  • Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer
  • Post-progression Nutritional and Immune Status Determines Survival After First-line Chemotherapy in Unresectable Advanced Gastric Cancer
  • Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire